Skip to:

"International public health experts: Hubei patients can only see the inflection point after all the patients are diagnosed"

China Philanthropist interviewed Dr. Zuo-Feng Zhang, a professor of epidemiology and associate dean for research at the UCLA Fielding School of Public health, on the novel coronavirus (COVID-19), and the test that China’s public health system faces.

Friday, February 7, 2020

According to the latest data from the National Health and Medical Commission of China, as of 24:00 on February 5, a total of 28,018 confirmed cases, 563 deaths, 1153 cured cases, and suspected cases were confirmed in 31 provinces (autonomous regions and municipalities) and the Xinjiang Production and Construction Corps. 24,702 cases.

At present, the number of patients with new pneumonia pneumonia infection and the rapid increase in a short period of time, putting tremendous pressure on treatment and prevention work, China's public health system is also facing new tests.

On February 5, "Chinese Philanthropist" interviewed Zuo-Feng Zhang, associate dean and senior tenured professor of epidemiology at the University of California, Los Angeles (UCLA) School of Public Health. Professor Zhang also serves as a member of the National Institutes of Health (NIH) Cancer Epidemiology Project Evaluation Panel, a senior member of the American Academy of Epidemiology, and a consultant for the prevention and treatment of chronic diseases at the World Health Organization. He is an internationally renowned public health expert.